Konidaris Tasos
SEC insider (Form 3/4/5 filer). CIK 0001320982. Executive Vice President & CFO at Amneal Pharmaceuticals, Inc. (AMRX). 28 reported Form 4/5 transactions since Sep 2024; latest on Mar 4, 2026. Located in BRIDGEWATER, NJ.
Companies Konidaris Tasos has filed insider reports for
- Amneal Pharmaceuticals, Inc. (AMRX): Officer, Executive Vice President & CFO
Konidaris Tasos
CIK: 0001320982
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Amneal Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (28 total)
- Mar 4, 2026AMRX
Amneal Pharmaceuticals, Inc.
Tax PaymentDirect22K shares at avg. $13.30$293K - Mar 4, 2026AMRX
Amneal Pharmaceuticals, Inc.
ExerciseDirect44K shares- - Mar 3, 2026AMRX
Amneal Pharmaceuticals, Inc.
Tax PaymentDirect16.2K shares at avg. $13.31$215K - Mar 3, 2026AMRX
Amneal Pharmaceuticals, Inc.
Tax PaymentDirect24.3K shares at avg. $13.31$323K - Mar 3, 2026AMRX
Amneal Pharmaceuticals, Inc.
ExerciseDirect28.5K shares- - Mar 3, 2026AMRX
Amneal Pharmaceuticals, Inc.
Tax PaymentDirect14.3K shares at avg. $13.31$190K - Mar 3, 2026AMRX
Amneal Pharmaceuticals, Inc.
Tax PaymentDirect229.8K shares at avg. $13.31$3.1M - Mar 3, 2026AMRX
Amneal Pharmaceuticals, Inc.
ExerciseDirect458.7K shares- - Mar 3, 2026AMRX
Amneal Pharmaceuticals, Inc.
ExerciseDirect57.3K shares- - Mar 3, 2026AMRX
Amneal Pharmaceuticals, Inc.
ExerciseDirect45.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 4, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Tax Payment | 22,035 | $13.30 | $293,066 | Direct |
| Mar 4, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Exercise | 43,982 | - | $0 | Direct |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Tax Payment | 16,182 | $13.31 | $215,382 | Direct |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Tax Payment | 24,251 | $13.31 | $322,781 | Direct |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Exercise | 28,538 | - | $0 | Direct |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Tax Payment | 14,298 | $13.31 | $190,306 | Direct |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Tax Payment | 229,817 | $13.31 | $3,058,864 | Direct |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Exercise | 458,716 | - | $0 | Direct |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Exercise | 57,339 | - | $0 | Direct |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Exercise | 45,290 | - | $0 | Direct |
1-10 of 28 transactions